medroxyprogesterone acetate has been researched along with Vulvitis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jackson, DJ; Kreiss, J; Lavreys, L; Mandaliya, K; Martin, HL; Ndinya-Achola, JO; Nyange, PM; Richardson, BA | 1 |
1 other study(ies) available for medroxyprogesterone acetate and Vulvitis
Article | Year |
---|---|
Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1.
Topics: Behavior; Candidiasis, Vulvovaginal; Contraception; Contraceptive Agents, Female; Contraceptive Devices; Demography; Female; HIV Seropositivity; HIV-1; Humans; Kenya; Medroxyprogesterone Acetate; Multivariate Analysis; Prospective Studies; Risk Factors; Sex Work; Sexually Transmitted Diseases; Ulcer; Vaginal Discharge; Vulvitis | 1998 |